Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...101102103104105106107108109110...
CompanyDrug NameStatusIndication Group
ViroPharma No drug name in Phase IIAnti-infectives for systemic use
Wyeth No drug name in Phase IAnti-infectives for systemic use
Enzo Biochem No drug name in Phase IIAnti-infectives for systemic use
SciClone No drug name in Phase IIAnti-infectives for systemic use
Schering-Plough No drug name accomplished Phase IAnti-infectives for systemic use
AstraZeneca No drug name in Phase IAnti-infectives for systemic use
GlobeImmune No drug name in Phase IAnti-infectives for systemic use
GlaxoSmithKline No drug name in Phase IIAnti-infectives for systemic use
AVI BioPharma No drug name accomplished Phase IAntineoplastic & immunomodulating agents
CuraGen No drug name in Phase IIAntineoplastic & immunomodulating agents
Dainippon Sumimoto Pharma No drug name in Phase IIAntineoplastic & immunomodulating agents
Progen Industries No drug name in Phase IAntineoplastic & immunomodulating agents
Progen Industries No drug name in Phase IIAntineoplastic & immunomodulating agents
Dyax No drug name accomplished Phase IIICardiovascular system
Genzyme No drug name in Phase IIICardiovascular system
Jerini No drug name Submitted for approval in USACardiovascular system
Baxter International No drug name accomplished Phase IIIRespiratory system
PDL Biopharma No drug name in Phase IIIGenito urinary system & sex hormones
Medivir No drug name in Phase IIAnti-infectives for systemic use
SkyePharma No drug name accomplished Phase IIAlimentary tract & metabolism
...101102103104105106107108109110...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.